Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Su M Metcalfe

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 9, 2005
Axotrophin and leukaemia inhibitory factor (LIF) in transplantation toleranceSu M Metcalfe
Stem Cells (Dayton, Ohio)|October 11, 2014
Stem cell therapy versus T lymphocytes: friend or foe?Su M Metcalfe
Multiple Sclerosis and Related Disorders|February 16, 2018
LIF and multiple sclerosis: One protein with two healing propertiesSu M Metcalfe
Medicine in Drug Discovery|April 17, 2020
Mesenchymal stem cells and management of COVID-19 pneumoniaSu M Metcalfe
Nature|September 17, 2011
Multiple sclerosis: One protein, two healing propertiesSu M Metcalfe
Trends in Molecular Medicine|December 17, 2011
Targeted nanotherapy for induction of therapeutic immune responsesSu M Metcalfe, Tarek M Fahmy
Current Pharmaceutical Design|December 8, 2016
Neurodegenerative Disease: A Perspective on Cell-Based Therapy in the New Era of Cell-Free Nano-TherapySu M Metcalfe, Sean Bickerton, Tarek Fahmy
International Immunopharmacology|December 14, 2004
Transplantation tolerance: gene expression profiles comparing allotolerance vs. allorejectionSu M Metcalfe, Poorni A De S Muthukumarana
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 9, 2005
Introduction: immunoregulation: harnessing T cell biology for therapeutic benefitSu M Metcalfe, Roy Y Calne, Stephen P Cobbold
Nanobiomedicine|June 27, 2018
Multiple Sclerosis and the LIF/IL-6 Axis: Use of Nanotechnology to Harness the Tolerogenic and Reparative Properties of LIFSu M Metcalfe, Terry B Strom, Anna Williams, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 9, 2005
Axotrophin and leukaemia inhibitory factor (LIF) in transplantation toleranceSu M Metcalfe
Stem Cells (Dayton, Ohio)|October 11, 2014
Stem cell therapy versus T lymphocytes: friend or foe?Su M Metcalfe
Multiple Sclerosis and Related Disorders|February 16, 2018
LIF and multiple sclerosis: One protein with two healing propertiesSu M Metcalfe
Medicine in Drug Discovery|April 17, 2020
Mesenchymal stem cells and management of COVID-19 pneumoniaSu M Metcalfe
Nature|September 17, 2011
Multiple sclerosis: One protein, two healing propertiesSu M Metcalfe
Trends in Molecular Medicine|December 17, 2011
Targeted nanotherapy for induction of therapeutic immune responsesSu M Metcalfe, Tarek M Fahmy
Current Pharmaceutical Design|December 8, 2016
Neurodegenerative Disease: A Perspective on Cell-Based Therapy in the New Era of Cell-Free Nano-TherapySu M Metcalfe, Sean Bickerton, Tarek Fahmy
International Immunopharmacology|December 14, 2004
Transplantation tolerance: gene expression profiles comparing allotolerance vs. allorejectionSu M Metcalfe, Poorni A De S Muthukumarana
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 9, 2005
Introduction: immunoregulation: harnessing T cell biology for therapeutic benefitSu M Metcalfe, Roy Y Calne, Stephen P Cobbold
Nanobiomedicine|June 27, 2018
Multiple Sclerosis and the LIF/IL-6 Axis: Use of Nanotechnology to Harness the Tolerogenic and Reparative Properties of LIFSu M Metcalfe, Terry B Strom, Anna Williams, et al.
Pageof 2